The NIH CounterACT program is offering this grant to support exploratory and developmental translational research aimed at creating therapeutics to reduce mortality and morbidity from acute chemical threat exposures. This grant is for the purpose of funding projects focused on countermeasures against chemical warfare agents (like sarin and VX), toxic industrial chemicals (e.g., cyanide), and toxic agricultural chemicals (e.g., parathion). Expected outcomes include generating critical preliminary preclinical, screening, and efficacy data. This foundational research is intended to enable the development of competitive applications for more extensive future support from the NIH CounterACT program and other related translational research initiatives.
Opportunity ID: 203193
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-005 |
| Funding Opportunity Title: | Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Environment Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.113 — Environmental Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 03, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 30, 2015 |
| Current Closing Date for Applications: | Jan 30, 2015 |
| Archive Date: | Mar 02, 2015 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses Special district governments Public housing authorities/Indian housing authorities State governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages applications for exploratory/developmental translational research on therapeutics for reducing mortality and morbidity caused by acute exposures to chemical threat agents. Chemical threats include chemical warfare nerve agents such as sarin and VX, toxic industrial chemicals such as cyanide and phosgene, and toxic agricultural chemicals such as parathion and sodium fluoroacetate. Projects supported by this FOA are expected to generate preliminary preclinical, screening and efficacy data that would enable the development of competitive applications for more extensive support from the NIH CounterACT program (see www.ninds.nih.gov/counteract for a description) and other related translational research programs. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-005.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00148630 | Dec 30, 2012 | Sep 24, 2013 | View | |
| FORMS-C | Use for due dates after 9/24/2013. | PKG00181190 | Sep 16, 2013 | Jan 30, 2015 | View |
Package 1
Mandatory forms
203193 RR_SF424_1_2-1.2.pdf
203193 PerformanceSite_1_4-1.4.pdf
203193 RR_OtherProjectInfo_1_3-1.3.pdf
203193 RR_KeyPersonExpanded_1_2-1.2.pdf
203193 PHS398_CoverPageSupplement_1_4-1.4.pdf
203193 PHS398_ResearchPlan_1_3-1.3.pdf
203193 PHS398_Checklist_1_3-1.3.pdf
Optional forms
203193 RR_SubawardBudget30-1.2.pdf
203193 PHS398_ModularBudget_1_2-1.2.pdf
203193 RR_Budget-1.1.pdf
203193 PHS_CoverLetter_1_2-1.2.pdf
Package 2
Mandatory forms
203193 RR_SF424_2_0-2.0.pdf
203193 PHS398_ResearchPlan_2_0-2.0.pdf
203193 PHS398_CoverPageSupplement_2_0-2.0.pdf
203193 RR_KeyPersonExpanded_2_0-2.0.pdf
203193 RR_OtherProjectInfo_1_3-1.3.pdf
203193 PerformanceSite_2_0-2.0.pdf
Optional forms
203193 RR_SubawardBudget30_1_3-1.3.pdf
203193 PlannedReport-1.0.pdf
203193 PHS398_CumulativeInclusionReport-1.0.pdf
203193 PHS398_ModularBudget_1_2-1.2.pdf
203193 RR_Budget_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
